8.18
price down icon0.12%   -0.010
after-market 시간 외 거래: 8.18
loading

Bausch Health Companies Inc 주식(BHC)의 최신 뉴스

pulisher
Nov 20, 2024

Aesthetic Devices Market in Mexico to Grow by USD 533.06 Million (2024-2028) as AI Impacts Market Trends, Rising Awareness Boosts RevenueTechnavio - Lelezard

Nov 20, 2024
pulisher
Nov 19, 2024

LMR Partners LLP Purchases Shares of 400,000 Bausch Health Companies Inc. (NYSE:BHC) - MarketBeat

Nov 19, 2024
pulisher
Nov 18, 2024

US Supreme Court declines to hear patent dispute over Bausch blockbuster diarrhea drug - Marketscreener.com

Nov 18, 2024
pulisher
Nov 18, 2024

Herpes Zoster Oticus Market: Company Profiles, Segment Sizes, - openPR

Nov 18, 2024
pulisher
Nov 18, 2024

Bausch Health and Salix to Present at the American Association for the Study of Liver Disease (AASLD) the RED-C Phase 3 Study Design for a New Investigational Product Designed to Address Serious Complications of Cirrhosis - AccessWire

Nov 18, 2024
pulisher
Nov 18, 2024

Bausch Health's Triple-Action Acne Treatment CABTREO Gains Key Canadian Approvals | BHC Stock News - StockTitan

Nov 18, 2024
pulisher
Nov 14, 2024

Common Warts Treatment Market Trade Analysis and Statistical - openPR

Nov 14, 2024
pulisher
Nov 14, 2024

Underactive Bladder Treatment Market Expected to Reach Huge - openPR

Nov 14, 2024
pulisher
Nov 13, 2024

Genital Herpes Treatment Market Global Share, Trends, Business - openPR

Nov 13, 2024
pulisher
Nov 13, 2024

Varicella Zoster (HHV-3) Infections Treatment Market Share, - openPR

Nov 13, 2024
pulisher
Nov 13, 2024

Vitrectomy Devices Market is expected to reach US$ 2121.3 - openPR

Nov 13, 2024
pulisher
Nov 12, 2024

22q11.2 Deletion Syndrome Market Forecasted to Surge in Coming Years, 2024-2034 Analysis by DelveInsight | Nobias Therapeutics, Zynerba Pharma, Bausch Health Americas - The Globe and Mail

Nov 12, 2024
pulisher
Nov 12, 2024

Actinic Keratosis Market Growth to Accelerate in Forecast Period (2023-2032), DelveInsight Analyze | Bausch Health Companies, Sandoz Pharma, Athenex, Almirall, Vidac Pharma, G&E Herbal Biotech - Barchart

Nov 12, 2024
pulisher
Nov 11, 2024

Periodontal Therapeutics Market to Grow at a Promising CAGR - openPR

Nov 11, 2024
pulisher
Nov 10, 2024

Bausch Health Companies: Top 25 Undervalued Toronto Stock Exchange Stocks (BHC) - Barchart

Nov 10, 2024
pulisher
Nov 07, 2024

Myopia and Presbyopia Treatment Market to Grow by USD 9.76 Billion from 2024-2028, as Rising Prevalence Drives Demand with AI Redefining Market LandscapeTechnavio - The Malaysian Reserve

Nov 07, 2024
pulisher
Nov 07, 2024

Are Medical Stocks Lagging Bausch Health (BHC) This Year? - MSN

Nov 07, 2024
pulisher
Nov 06, 2024

Body Contouring Treatments Market to Hit USD 2.58 Billion by 2029 with 10.0% CAGR | MarketsandMarkets™ - The Manila Times

Nov 06, 2024
pulisher
Nov 06, 2024

Eye Health Supplements Market Trends and Growth Projections - openPR

Nov 06, 2024
pulisher
Nov 05, 2024

Gastroparesis Drugs Market to Grow by USD 1.42 Billion from 2024-2028, Driven by Rising Diabetes Rates and AI-Driven Market Trend InsightsTechnavio - The Malaysian Reserve

Nov 05, 2024
pulisher
Nov 05, 2024

189,000 Shares in Bausch Health Companies Inc. (NYSE:BHC) Bought by Intact Investment Management Inc. - MarketBeat

Nov 05, 2024
pulisher
Nov 04, 2024

Bausch Health Companies' SWOT analysis: debt woes cloud strong Q3 stock performance - Investing.com

Nov 04, 2024
pulisher
Nov 04, 2024

Why Bausch Health (BHC) is a Top Momentum Stock for the Long-Term - Yahoo Finance

Nov 04, 2024
pulisher
Nov 02, 2024

Bausch Health Q3 Earnings and Revenues Top, Xifaxan Boosts Sales - MSN

Nov 02, 2024
pulisher
Nov 02, 2024

Bausch Health Companies Inc. (NYSE:BHC) Given Consensus Recommendation of "Hold" by Analysts - MarketBeat

Nov 02, 2024
pulisher
Nov 01, 2024

Bausch Health secures $400 million loan amendment - Investing.com

Nov 01, 2024
pulisher
Nov 01, 2024

Bausch Health secures $400 million loan amendment By Investing.com - Investing.com UK

Nov 01, 2024
pulisher
Nov 01, 2024

Bausch Health Companies (NYSE:BHC) Price Target Raised to $11.00 at Royal Bank of Canada - MarketBeat

Nov 01, 2024
pulisher
Nov 01, 2024

Bausch Health Companies Inc. (NYSE:BHC) Q3 2024 Earnings Call Transcript - Insider Monkey

Nov 01, 2024
pulisher
Nov 01, 2024

Bausch Health Companies Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags - Simply Wall St

Nov 01, 2024
pulisher
Nov 01, 2024

Bausch Health stock outlook lifted as RBC cites robust Q3 growth and tax benefits - Investing.com

Nov 01, 2024
pulisher
Oct 31, 2024

Traders Purchase High Volume of Bausch Health Companies Put Options (NYSE:BHC) - MarketBeat

Oct 31, 2024
pulisher
Oct 31, 2024

Toronto Stocks Drop, Canada's GDP Flat in August; Bausch Health Rises on 3Q Beat - Marketscreener.com

Oct 31, 2024
pulisher
Oct 31, 2024

Bausch Health Shares Rise on FY Outlook Upgrade, 3Q Beat - MarketWatch

Oct 31, 2024
pulisher
Oct 31, 2024

Bausch Health Companies (NYSE:BHC) Trading 8.7% Higher on Better-Than-Expected Earnings - MarketBeat

Oct 31, 2024
pulisher
Oct 31, 2024

Bausch Health Companies (TSE:BHC) Stock Price Up 8.4% Following Earnings Beat - MarketBeat

Oct 31, 2024
pulisher
Oct 31, 2024

BHCBausch Health Companies Inc. Latest Stock News & Market Updates - StockTitan

Oct 31, 2024
pulisher
Oct 31, 2024

Bausch: Q3 Earnings Snapshot - Houston Chronicle

Oct 31, 2024
pulisher
Oct 31, 2024

Bausch Health Reports Growth Amid Improved Financials - TipRanks

Oct 31, 2024
pulisher
Oct 30, 2024

Compared to Estimates, Bausch (BHC) Q3 Earnings: A Look at Key Metrics - Yahoo Finance

Oct 30, 2024
pulisher
Oct 30, 2024

Bausch Health (BHC) Beats Q3 Earnings and Revenue Estimates - Yahoo Finance

Oct 30, 2024
pulisher
Oct 30, 2024

Bausch Health Companies Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Oct 30, 2024
pulisher
Oct 30, 2024

Bausch Health Announces Third Quarter 2024 Results - AccessWire

Oct 30, 2024
pulisher
Oct 30, 2024

Gastroparesis Treatment Market Top Trends and Growth Analysis: - openPR

Oct 30, 2024
pulisher
Oct 29, 2024

Bausch Health Companies Q3 2024 Earnings Preview - MSN

Oct 29, 2024
pulisher
Oct 29, 2024

Onychomycosis Treatment Market Size, Industry Analysis, - openPR

Oct 29, 2024
pulisher
Oct 29, 2024

Actinic Keratosis Treatment Market Expected to Reach Huge - openPR

Oct 29, 2024
pulisher
Oct 29, 2024

Canada Aesthetic Devices Market Size, Share, Industry Growth, - openPR

Oct 29, 2024
pulisher
Oct 28, 2024

Bausch Health Companies Inc. and Salix Pharmaceuticals Announce Results of an Analysis of Xifaxan Monotherapy Will Be Presented During A Presidential Plenary Session of the American College of Gastroenterology 2024 Annual Scientific Meeting Taking - Marketscreener.com

Oct 28, 2024
pulisher
Oct 27, 2024

ACG Presidential Plenary to Highlight Analysis of Xifaxan(R) (rifaximin) Risk Reduction of Overt Hepatic Encephalopathy (OHE) Recurrence - StockTitan

Oct 27, 2024
pulisher
Oct 26, 2024

TD COWEN Downgrades Bausch Health Companies (BHC) - MSN

Oct 26, 2024
pulisher
Oct 26, 2024

Deal Dispatch: TKO Buys Bull Riding, Radford Motors Is BankruptApollo Global Management (NYSE:APO), Bausch Health Companies (NYSE:BHC) - Benzinga

Oct 26, 2024
pulisher
Oct 25, 2024

Bausch Health Companies (NYSE:BHC) Lifted to "Buy" at StockNews.com - MarketBeat

Oct 25, 2024
pulisher
Oct 24, 2024

FY2024 EPS Estimates for TSE:BHC Lifted by Zacks Research - MarketBeat

Oct 24, 2024
pulisher
Oct 23, 2024

2024 Research | Europe Retinal Surgery Devices Market Poised for Growth, Expected to Reach $1.16 Billion by 2032, Driven by Rising Prevalence of Retinal Diseases and Technological Advancements - GlobeNewswire Inc.

Oct 23, 2024
pulisher
Oct 23, 2024

Bausch Health (BHC) Reports Next Week: What to Expect - Yahoo Finance

Oct 23, 2024
pulisher
Oct 23, 2024

What is Zacks Research's Forecast for BHC Q3 Earnings? - MarketBeat

Oct 23, 2024
pulisher
Oct 23, 2024

Zacks Research Has Positive Outlook for TSE:BHC Q3 Earnings - MarketBeat

Oct 23, 2024
pulisher
Oct 23, 2024

Bausch Health Companies (BHC) Set to Announce Earnings on Wednesday - MarketBeat

Oct 23, 2024
pulisher
Oct 23, 2024

Bausch Health Companies (BHC) Scheduled to Post Earnings on Wednesday - MarketBeat

Oct 23, 2024
$87.32
price up icon 1.01%
$13.40
price down icon 0.30%
$85.45
price down icon 0.22%
$59.66
price up icon 1.12%
$125.00
price up icon 1.39%
$13.25
price up icon 0.91%
자본화:     |  볼륨(24시간):